Table 4 Univariate analysis of risk factors for CMV IgG positive in patients with inflammatory bowel disease

Age

Number

P value

OR (95% CI)

Number

P value

OR (95% CI)

 ≤50 ys

107/32

0.074

1.881 (0.934 ~ 3.786)

21/3

1.000

0.583 (0.054 ~ 6.251)

 >50 ys

32/18

12/1

Sex

 male

82/27

0.540

1.225 (0.639 ~ 2.349)

21/2

0.625

1.750 (0.218 ~ 14.069)

 female

57/23

12/2

Smoking

 yes

32/13

0.672

0.851 (0.404 ~ 1.793)

9/0

0.554

N/A

 no

107/37

24/4

Drinking

 Yes

53/22

0.467

0.784 (0.407 ~ 1.510)

10/2

0.582

0.435 (0.053 ~ 3.536)

 no

86/28

23/2

Diet composition

 vegetarian food

14/4

0.883

1.288 (0.403 ~ 4.115)

3/3

0.010*

0.033 (0.003 ~ 0.429)

 mixed food

125/46

30/1

Fever

 yes

26/6

0.278

1.687 (0.650 ~ 4.379)

4/0

1.000

N/A

 no

113/44

29/4

Hemoglobin (G/L)

 ≤70

7/2

1.000

1.273 (0.255 ~ 6.341)

0/0

-

N/A

 >70

132/48

33/4

Albumin (G/L)

 ≤35

16/5

0.771

1.171 (0.405 ~ 3.381)

11/2

0.602

0.500 (0.062 ~ 4.040)

 >35

123/45

22/2

Disease severity

 mild and moderate

120/48

0.109

0.263 (0.059 ~ 1.173)

26/4

0.570

N/A

 severe

19/2

7/0

Location

 distal colitis

108/32

0.058

1.960 (0.971 ~ 3.955)

 pancolitis

31/18

 ileal

7/1

0.219

N/A

 Colonic

14/0

 ileocolon

12/3

Treatment

ASA/SASP

119/30

<0.001*

3.967 (1.897 ~ 8.296)

18/2

1.000

1.200 (0.150 ~ 9.570)

corticosteroids

38/9

0.190

1.714 (0.761 ~ 3.861)

8/0

0.557

N/A

immunosuppressant

5/0

0.328

N/A

2/0

1.000

N/A